Modulating MGMT expression through interfering with cell signaling pathways

Peiying Bai1, Tengjiao Fan2, Xin Wang3

  • 1Beijing Key Laboratory of Environmental and Viral Oncology, Faculty of Environment and Life, Beijing University of Technology, Beijing 100124, China.

PubMed

Insights

Chemoresistance to DNA alkylating agents is often caused by O6-methylguanine-DNA methyltransferase (MGMT). Targeting MGMT expression through cell signaling pathways offers a promising strategy to enhance chemotherapy efficacy and overcome tumor resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Guanine O6-alkylating agents are crucial chemotherapeutics inducing DNA damage.
  • Tumor resistance to these agents is frequently mediated by O6-methylguanine-DNA methyltransferase (MGMT).
  • MGMT repairs lethal O6-alkylguanine adducts, enabling cancer cells to evade apoptosis and develop resistance.

Purpose of the Study:

  • To address the limitations of current MGMT inhibitors, such as O6-benzylguanine (O6-BG) and O6-(4-bromothenyl)guanine (O6-4-BTG), which cause significant toxicity.
  • To explore novel therapeutic strategies for overcoming MGMT-mediated chemoresistance.
  • To investigate the potential of targeting cell signaling pathways regulating MGMT expression.

Main Methods:

  • Review of existing literature on DNA alkylating agents, MGMT, and chemoresistance mechanisms.
  • Analysis of clinical data regarding the efficacy and toxicity of MGMT inhibitors.
  • Exploration of cell signaling pathways (Wnt/β-catenin, NF-κB, Hedgehog, PI3K/AKT/mTOR, JAK/STAT) involved in MGMT regulation.

Main Results:

  • O6-BG and O6-4-BTG show limited clinical utility due to severe delayed hematological toxicity.
  • MGMT's role in repairing DNA damage and conferring resistance is well-established.
  • Several cell signaling pathways are implicated in the regulation of MGMT expression.

Conclusions:

  • There is a critical need for alternative strategies to overcome MGMT-mediated chemoresistance.
  • Targeting the regulation of MGMT expression via specific cell signaling pathways presents a promising approach.
  • Interfering with these pathways could enhance the efficacy of DNA alkylating agents in chemotherapy.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Diversity in Cell Signaling Responses01:22

Diversity in Cell Signaling Responses

The physiological function of a cell and cellular communication are outcomes of a range of extrinsic signals, intracellular signaling pathways, and cellular responses. No two cell types express the same repertoire of signaling components. Receptors are highly selective for their cognate ligands, but once activated, they can alter multiple cellular processes such as DNA transcription, protein synthesis, and metabolic activity. 
Graded and Abrupt Responses
Some signaling systems generate...
6.5K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
944
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
22.8K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K